LINC01153: A Potential Drug Target and Biomarker (G101927889)

Target Name: LINC01153

NCBI ID: G101927889

LINC01153

Other Name(s): Long intergenic non-protein coding RNA 1153 | long intergenic non-protein coding RNA 1153

LINC01153: A Potential Drug Target and Biomarker

LINC01153 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as having various functions in various organisms, including humans. This RNA is unique because of its ability to interact with proteins and other RNAs, making it a potential drug target and biomarker. In this article, we will explore the biology and potential applications of LINC01153.

Biology of LINC01153

LINC01153 is a transcribed RNA molecule that is located between the 5' and 3' ends of the coding gene for the protein known as E2F1. The protein encoded by this gene is a transcription factor that plays a role in the regulation of gene expression. LINC01153 is a non-coding RNA molecule that is derived from the intron of the E2F1 gene.

Studies have shown that LINC01153 is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, LINC01153 has been shown to play a role in the regulation of cell cycle progression in various organisms, including humans. Additionally, LINC01153 has been shown to be involved in the regulation of apoptosis, which is the process by which cells die naturally in the body.

Potential Applications of LINC01153

The potential applications of LINC01153 as a drug target and biomarker are vast. One of the most promising applications is the use of LINC01153 as a target for small molecule inhibitors. due to its unique biology and the various cellular processes that it is involved in, LINC01153 is seen as a promising target for small molecules that can modulate its function.

In addition to its potential as a drug target, LINC01153 has also been shown to be a potential biomarker for various diseases, including cancer. This is because of its involvement in the regulation of cellular processes that are often disrupted in cancer cells, such as cell cycle progression and apoptosis. By using LINC01153 as a biomarker, researchers can monitor the effectiveness of cancer treatments and track disease progression.

Conclusion

In conclusion, LINC01153 is a unique and promising molecule that has the potential to be a drug target and biomarker. Its biology and various cellular processes make it an attractive target for small molecule inhibitors, and its involvement in the regulation of cellular processes that are often disrupted in cancer cells makes it an promising biomarker for disease tracking. Further research is needed to fully understand the potential applications of LINC01153, and to determine its effectiveness as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1153

The "LINC01153 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01153 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets